Health · Healthcare & Policy · 8 hrs ago
L’Oréal settles US claims by four women over hair relaxer
L’Oréal settled claims brought by four Black women in the United States who said a hair relaxer sold by the cosmetics company caused their cancers.
The agreement was reached at an Illinois court on Monday, but the payment amount was not disclosed.
The company faces many other civil claims in the United States alleging that hair-straightening products increase cancer risk, particularly for Black women.
A 2022 study by the US National Institutes of Health found that frequent use of hair relaxers was linked to more than double the risk of uterine cancer.
L’Oréal says its products are safe, citing scientific safety reviews and compliance with regulations.
Many other claims against the company remain, while the four women’s lawyer said she would continue seeking justice and stronger protections and warnings.
L’Oréal reached a settlement with four African-American women who sued the company in the United States over a hair relaxer they said caused their cancers.
The agreement was concluded Monday in an Illinois court, and its financial terms were not disclosed.
The company faces numerous civil lawsuits in the United States over claims that hair relaxers increase cancer risk.
L’Oréal said its products undergo rigorous scientific safety assessments and that consumer health is its highest priority.
A 2022 study by the US National Institutes of Health found frequent use of hair relaxers was linked to more than double the risk of uterine cancer.
- Who
- L’Oréal and four African-American women: MaryAnne, Surenthia, Miranda and Sandra.
- What
- They reached a settlement over the women’s claims that a L’Oréal hair relaxer caused their cancers. The settlement amount was not disclosed.
- When
- The agreement was concluded Monday; the report was published on November 17, 2026.
- Where
- An Illinois court in the United States.
- Why
- The women said a hair relaxer marketed by L’Oréal was responsible for their cancers. L’Oréal defended the safety of its products.
The four plaintiffs
L’Oréal
Product safety
The four plaintiffs
The plaintiffs’ lawyer said the women trusted assurances that the products were safe and paid a high price for that trust.
L’Oréal
L’Oréal said its products undergo rigorous scientific safety assessments and that it follows regulations in every market where it operates.
Justice and protections
The four plaintiffs
The plaintiffs’ lawyer said every woman harmed by the products deserves justice and called for stronger protections and honest safety warnings.
L’Oréal
Not stated
A study published by the US National Institutes of Health linked frequent hair relaxer use to more than double the risk of uterine cancer.
L’Oréal reached an agreement with the four women before an Illinois court; the settlement amount was not made public.
Le Monde reported the agreement.
- Plaintiffs
- Four African-American women: MaryAnne, Surenthia, Miranda and Sandra
- Settlement venue
- An Illinois court
- Settlement amount
- Not disclosed
- Study year
- 2022
- Frequent use in study
- More than four times per year
What people are saying
These women trusted the defendants’ assurances that their hair-straightening products were safe, and they paid dearly for that trust.
This is an important step, but our mission is far from accomplished.
Our products undergo rigorous scientific safety assessments by experts who also ensure that we strictly follow all regulations in every market where we operate.
The health and well-being of our consumers are our highest priority.